Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Aging

3,4-dihydroxyphenylacetic acid has been researched along with Aging in 164 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.

Research Excerpts

ExcerptRelevanceReference
"Haloperidol treatment (2 hours) accelerated striatal DA turnover similarly in all age groups, by about 100%."5.26Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice. ( Finch, CE; Osterburg, HH; Severson, JA, 1981)
"Children whose mothers used cocaine during pregnancy appear to have an increased incidence of certain neurobehavioral deficits."3.71Prenatal cocaine exposure increases mesoprefrontal dopamine neuron responsivity to mild stress. ( Elsworth, JD; Morrow, BA; Roth, RH, 2001)
"The aging of the cochlear dopaminergic system has been analyzed by quantifying the levels of dopamine (DA) and its metabolites (3,4-dihydroxyphenylacetic acid, DOPAC, and homovanillic acid, HVA) in adult rats aged 3, 12 or 24 months."3.71Effects of aging on cochlear monoamine turnover. ( Dávila, D; Gil-Loyzaga, P; Muñoz, E; Vicente-Torres, MA, 2002)
"Taurine is present in high concentration in the mammalian brain and is known to decline with aging."3.70An age-related decline in striatal taurine is correlated with a loss of dopaminergic markers. ( Cullen, MJ; Dawson, R; Gollub, M; Liu, S; Pelleymounter, MA, 1999)
" In addition, the exposure to new environmental condition elevated blood corticosterone levels and enhanced behavioral activities to a greater extent in the Dex group than in controls at 7 wk of life, suggesting that elevated glucocorticoid levels during the pregnancy mimicked prenatal mild stress, producing developmental alterations in brain monoamine metabolism, endocrine response, and behavior in adult offspring."3.69Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring. ( Kamei, K; Kitera, K; Mikuni, M; Muneoka, K; Ogawa, T; Takahashi, K; Takigawa, M, 1997)
" The results indicate that aging did not significantly alter the levels of norepinephrine (NE), dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in frontal (FCX), parietal (PCX) and occipital cortices (OCX)."3.68Effect of aging and diet restriction on monoamines and amino acids in cerebral cortex of Fischer-344 rats. ( Friedman, E; Yeung, JM, 1991)
"The long-term effect of the parkinsonism-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central monoaminergic neurons in young (2-3 months) and aging (12 months) C57BL/6 mice has been studied using neurochemical and immunocytochemical techniques."3.68Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. ( Date, I; Felten, DL; Felten, SY, 1990)
" Neither cortical NE nor its metabolite methoxyhydroxyphenylglycol sulphate (MHPG-SO4) were significantly changed by aging."3.67Effect of aging on monoamines and their metabolites in the rat brain. ( Carfagna, N; Moretti, A; Trunzo, F, 1987)
"Levodopa (l-DOPA, l-3,4-dihydroxyphenylalanine) is the most effective drug in the symptomatic treatment of Parkinson's disease (PD), but chronic use initiates a maladaptive process leading to l-DOPA-induced dyskinesia (LID)."1.46Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia. ( Andersen, AD; Binzer, M; Blaabjerg, M; Gramsbergen, JBP; Kamal, A; Kjaer, TW; Stenager, E; Thagesen, H, 2017)
"Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder of mature and older individuals."1.36Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. ( Charlton, CG; King, J; Mackey, V; Muthian, G, 2010)
" Although increasing the dosage of d-METH (20 to 80 mg/kg) did increase the GFAP response (100% over control), it was still well below that usually exhibited at the usual neurotoxic dosage (300-400% over control) in fully mature mice."1.31Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. ( Ali, SF; Miller, DB; O'Callaghan, JP, 2000)
" A treatment history of high AMPH dosage was associated with a marked sensitization of the exploratory behavior in adults, whereas it induced a quite opposite profile in periadolescents."1.31Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats. ( Laviola, G; Pascucci, T; Pieretti, S, 2001)
"The Fragile X syndrome, a common form of mental retardation in humans, is caused by silencing the fragile X mental retardation (FMR1) gene leading to the absence of the encoded fragile X mental retardation protein 1 (FMRP)."1.31Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. ( Braun, K; Gruss, M, 2001)
"Nomifensine treatment significantly increased TH enzyme amount in substantia nigra (39."1.30Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra. ( Cano, J; Machado, A; Rodríguez-Gómez, JA; Romero-Ramos, M; Venero, JL, 1997)
"Sodium azide is an inhibitor of cytochrome oxidase which produces selective striatal lesions in both rodents and primates."1.29Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism. ( Beal, MF; Brouillet, E; Henshaw, DR; Hyman, BT; Jenkins, BG; Rosen, BR; Schulz, JB; Sodhi, P, 1994)
" These results suggest that SAM rapidly undergoes neurochemical changes which are considered to be part of the normal aging process, and these changes were attenuated by chronic administration of nimodipine."1.29Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine. ( Kabuto, H; Mori, A; Murakami, M; Sawada, S; Yokoi, I, 1995)
" Reducing the ET to 4 degrees C during dosing decreased the peak and average DA levels attained during the 4 x 5 mg/kg METH administration to about 50% of that observed at a 23 degrees C ET."1.29Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. ( Bowyer, JF; Gough, B; Holson, RR; Lipe, GW; Newport, GD; Slikker, W, 1993)
" Eighteen-day-old rats were 35% and 63% more sensitive than adults to the effects of haloperidol on striatal and accumbens turnover and had steeper dose-response curves."1.29Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. ( Baldessarini, RJ; Barber, NI; Campbell, A; Gallitano, AL; Gelbard, HA; Marsh, E; Teicher, MH, 1993)
" A dose-response effect of apomorphine on extracellular dopamine was observed in all age groups except at 10-11 days of age."1.29The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on spontaneous release. ( Andersen, SL; Gazzara, RA, 1993)
" Part 1 of the study established a dose-response curve and the temporal pattern of GSH loss and recovery in the substantia nigra and striatum following acute BSO treatment."1.29Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. ( Andersen, JK; Hamill, RW; Harnish, P; Hom, DG; Lee, FY; McNeill, TH; Mo, JQ, 1996)
"Biogenic amines in pons and striatum have been dosed in twenty-four months old Wistar male rats."1.27[Biochemical changes in 24-month-old Wistar rats]. ( Della Zuana, O; Duhault, J; Lonchampt, M; Roman, F; Saint Romas, G, 1984)
" Two different dosage schedules of MPTP, i."1.27Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice. ( Mizuno, Y; Niijima, K; Saitoh, T, 1987)
"Haloperidol treatment (2 hours) accelerated striatal DA turnover similarly in all age groups, by about 100%."1.26Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice. ( Finch, CE; Osterburg, HH; Severson, JA, 1981)

Research

Studies (164)

TimeframeStudies, this research(%)All Research%
pre-199030 (18.29)18.7374
1990's82 (50.00)18.2507
2000's37 (22.56)29.6817
2010's15 (9.15)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Y1
Sun, Y1
Yang, J1
Wu, Y1
Yu, J1
Li, B1
Mora-Gallegos, A1
Rojas-Carvajal, M1
Salas, S1
Saborío-Arce, A1
Fornaguera-Trías, J1
Brenes, JC1
Didriksen, M1
Fejgin, K1
Nilsson, SR1
Birknow, MR1
Grayton, HM1
Larsen, PH1
Lauridsen, JB1
Nielsen, V1
Celada, P1
Santana, N1
Kallunki, P1
Christensen, KV1
Werge, TM1
Stensbøl, TB1
Egebjerg, J1
Gastambide, F1
Artigas, F1
Bastlund, JF1
Nielsen, J1
Bergen, MA1
Park, HN1
Chakraborty, R1
Landis, EG1
Sidhu, C1
He, L1
Iuvone, PM2
Pardue, MT1
Andersen, AD1
Blaabjerg, M1
Binzer, M1
Kamal, A1
Thagesen, H1
Kjaer, TW1
Stenager, E1
Gramsbergen, JBP1
Minematsu, M1
Nakajima, K1
Topic, B1
Oitzl, MS1
Meijer, OC1
Huston, JP1
de Souza Silva, MA1
Ling, Z1
Zhu, Y1
Tong, CW1
Snyder, JA1
Lipton, JW1
Carvey, PM1
Natividad, LA1
Tejeda, HA1
Torres, OV1
O'Dell, LE1
Dluzen, DE4
Ji, J1
McDermott, JL4
Heermann, S1
Opazo, F1
Falkenburger, B1
Krieglstein, K1
Spittau, B1
Li, CR1
Huang, GB1
Sui, ZY1
Han, EH1
Chung, YC1
Muthian, G1
Mackey, V1
King, J1
Charlton, CG1
Oyama, G1
Yoshimi, K1
Natori, S1
Chikaoka, Y1
Ren, YR1
Funayama, M1
Shimo, Y1
Takahashi, R1
Nakazato, T1
Kitazawa, S1
Hattori, N1
Allen, E1
Carlson, KM1
Zigmond, MJ2
Cavanaugh, JE1
Schumm, S1
Sebban, C1
Cohen-Salmon, C2
Callebert, J1
Launay, JM2
Golmard, JL1
Boussicault, L1
Petropoulos, I1
Hild, A1
Rousselet, E1
Prigent, A1
Friguet, B1
Mariani, J1
Hirsch, EC1
Wu, G1
Lu, ZH1
Kulkarni, N1
Ledeen, RW1
Pruett, BS1
Salvatore, MF1
Miura, H1
Qiao, H1
Ohta, T1
Stanford, JA3
Vorontsova, E1
Surgener, SP1
Gerhardt, GA5
Fowler, SC1
Purdom, MS2
Currier, TD1
Dietz, DM1
Pletnikov, MV1
Alquicer, G1
Silva-Gómez, AB1
Peralta, F1
Flores, G1
Pardon, MC1
Hanoun, N1
Perez-Diaz, F1
Joubert, C1
Christen, Y1
Hamon, M1
Saito, S1
Takagi, T1
Koutoku, T1
Saito, ES1
Hirakawa, H1
Tomonaga, S1
Tachibana, T1
Denbow, DM1
Furuse, M1
Segovia, G1
Mora, F1
Götz, ME1
Malz, CR1
Dirr, A1
Blum, D1
Gsell, W1
Schmidt, S1
Burger, R1
Pohli, S1
Riederer, P1
Boyce, PJ1
Finlay, JM1
Chanut, E1
Labarthe, B1
Lacroix, B1
Noda, A1
Gasdeblay, S1
Bondier, JR1
Versaux-Botteri, C1
Hamaue, N1
Ogata, A1
Terado, M1
Ohno, K1
Kikuchi, S1
Sasaki, H1
Tashiro, K1
Hirafuji, M1
Minami, M1
Villégier, AS1
Lotfipour, S1
McQuown, SC1
Belluzzi, JD1
Leslie, FM1
Sawada, H1
Hishida, R1
Hirata, Y1
Ono, K1
Suzuki, H1
Muramatsu, S1
Nakano, I1
Nagatsu, T1
Sawada, M1
Roman, F1
Della Zuana, O1
Lonchampt, M1
Saint Romas, G1
Duhault, J1
Simpkins, JW1
Lasley, SM1
Greenland, RD1
Minnema, DJ1
Michaelson, IA1
Ponzio, F1
Calderini, G2
Lomuscio, G1
Vantini, G1
Toffano, G3
Algeri, S1
Yoshino, K1
Riccardi, F1
Covelli, V1
Spano, PF2
Govoni, S2
Trabucchi, M3
Montefusco, O1
Missale, C1
Rozzini, R1
Osterburg, HH3
Donahue, HG1
Severson, JA2
Finch, CE3
Roth, BL1
Galloway, MP1
Coscia, CJ1
Memo, M1
Lucchi, L1
Venero, JL5
de la Roza, C1
Machado, A9
Cano, J9
Henderson, MG1
McMillen, BA1
Jinnah, HA1
Wojcik, BE1
Hunt, M1
Narang, N1
Lee, KY1
Goldstein, M1
Wamsley, JK1
Langlais, PJ1
Friedmann, T1
Brouillet, E1
Hyman, BT1
Jenkins, BG1
Henshaw, DR1
Schulz, JB1
Sodhi, P1
Rosen, BR1
Beal, MF1
Irwin, I1
DeLanney, LE1
McNeill, T1
Chan, P1
Forno, LS1
Murphy, GM1
Di Monte, DA1
Sandy, MS1
Langston, JW1
Gupta, M1
Wiener, HL1
Kabuto, H1
Yokoi, I1
Mori, A1
Murakami, M1
Sawada, S1
Armando, I1
Nowicki, S1
Aguirre, J1
Barontini, M1
Erdtsieck-Ernste, EB1
Feenstra, MG1
Botterblom, M1
Boer, GJ1
Ali, SF6
Holson, RR2
Newport, GD3
Slikker, W3
Bowyer, JF2
Gilad, GM1
Li, R1
Wyatt, RJ1
Tizabi, Y1
Santiago, M4
Crawford, CA1
McDougall, SA1
Bardo, MT1
David, SN1
Cadet, JL1
Navarro, M1
Rodríguez de Fonseca, F1
Hernández, ML2
Ramos, JA3
Fernández-Ruiz, JJ2
Tsai, YF1
Tsai, HW1
Tai, MY1
Budygin, EA1
Kovalev, GI1
Gaĭntdinov, RR1
Kudrin, VS2
Voronina, TA1
Stewart, J1
Rajabi, H1
Gough, B1
Lipe, GW1
Tsuchida, K1
Ujike, H1
Kanzaki, A1
Fujiwara, Y1
Akiyama, K1
Joseph, SA1
Walker, DW1
Gazzara, RA2
Andersen, SL2
Teicher, MH1
Barber, NI1
Gelbard, HA1
Gallitano, AL1
Campbell, A1
Marsh, E1
Baldessarini, RJ1
Desole, MS1
Esposito, G1
Enrico, P1
Miele, M1
Fresu, L1
De Natale, G1
Miele, E1
Grella, G1
Afonso, D2
Santana, C2
Rodriguez, M2
Yao, H1
Nagao, T1
Ooboshi, H1
Matsumoto, T1
Hirano, M1
Nakahara, T1
Sadoshima, S1
Uchimura, H1
Fujishima, M1
Rose, S2
Nomoto, M1
Jackson, EA1
Gibb, WR1
Jaehnig, P1
Jenner, P2
Marsden, CD2
Jensen, EW1
Eldrup, E2
Kelbaek, H1
Nielsen, SL1
Christensen, NJ2
Cabib, S1
Puglisi-Allegra, S1
D'Amato, FR1
Hastings, JA3
Pavia, JM2
Morris, MJ3
Woods, JM1
Druse, MJ1
Nakano, M1
Mizuno, T1
Andersen, JK1
Mo, JQ1
Hom, DG1
Lee, FY1
Harnish, P1
Hamill, RW1
McNeill, TH1
Ueda, Y1
Komatsu, M1
Hiramatsu, M1
Cransac, H1
Peyrin, L2
Cottet-Emard, JM1
Farhat, F1
Pequignot, JM1
Reber, A1
Bonnin, A1
de Miguel, R2
Castro, JG1
Penit-Soria, J1
Durand, C1
Herve, D1
Besson, MJ1
Schneider, JS2
Romero-Ramos, M1
Rodríguez-Gómez, JA1
Sajnani, GG1
Abreu, P1
Castro, R1
Muneoka, K1
Mikuni, M1
Ogawa, T1
Kitera, K1
Kamei, K1
Takigawa, M1
Takahashi, K1
McClure-Sharp, JM1
Hebert, MA1
Philpot, RM2
Kirstein, CL2
Schneider, ML1
Clarke, AS1
Kraemer, GW2
Roughton, EC1
Lubach, GR1
Rimm-Kaufman, S1
Schmidt, D1
Ebert, M1
Míguez, JM1
Recio, J1
Sánchez-Barceló, E1
Aldegunde, M1
Lemierre, S1
Rouch, C1
Nicolaidis, S1
Orosco, M1
Maloney, RE1
Dawson, R1
Pelleymounter, MA1
Cullen, MJ1
Gollub, M1
Liu, S1
Kucherianu, VG1
Kryzhanovskiĭ, GN1
Iurasov, VV1
Nikushkin, EV1
Zhigal'tsev, IV1
Goettl, VM1
Wemlinger, TA1
Duchemin, AM1
Neff, NH1
Hadjiconstantinou, M1
Vieira-Coelho, MA1
Hussain, T1
Kansra, V1
Serrao, MP1
Guimaraes, JT1
Pestana, M2
Soares-Da-Silva, P4
Lokhandwala, MF1
Ueda, S1
Aikawa, M1
Ishizuya-Oka, A1
Yamaoka, S1
Koibuchi, N1
Yoshimoto, K1
Shui, H1
Peng, Y1
Wu, R1
Tsai, Y1
Miller, DB1
O'Callaghan, JP1
Mandavilli, BS1
Van Houten, B1
MohanKumar, PS1
MohanKumar, SM1
Quadri, SK1
Voogt, JL1
Lee, JJ1
Chang, CK1
Liu, IM1
Chi, TC1
Yu, HJ1
Cheng, JT1
Laviola, G1
Pascucci, T1
Pieretti, S1
Fox, CM1
Gash, DM1
Smoot, MK1
Cass, WA1
Bairam, A1
Néji, H1
Kinkead, R1
Marchal, F1
Campbell, BM1
Gresch, PJ1
Walker, PD1
Ferreira, A1
Bettencourt, P1
Correia, F1
Serrão, P1
Martins, L1
Cerqueira-Gomes, M1
Imam, SZ1
Elsworth, JD1
Morrow, BA1
Roth, RH1
Vicente-Torres, MA2
Muñoz, E2
Dávila, D2
Gil-Loyzaga, P2
Gruss, M1
Braun, K1
Meyer, JS1
Summavielle, T1
Magalhães, A1
Castro-Vale, I1
de Sousa, L1
Tavares, MA1
Muskiet, FA1
Fremouw-Ottevangers, DC1
van der Meulen, J1
Wolthers, BG1
de Vries, JA1
Dalmaz, Y1
Sann, L1
Dutruge, J1
Davis, AJ1
Holzbauer, M1
Sharman, DF1
Fernandes, MH2
Fernandez-Ruiz, J1
Cebeira, M1
Pasinetti, GM1
Kelly, AB1
Kohama, S1
Morgan, DG1
Reinhard, JF1
Stellwagen, RH1
Arevalo, R1
Darney, KJ1
Goldman, JM1
Vandenbergh, JG1
Martineau, J1
Garreau, B1
Barthélémy, C1
Jouve, J1
Lelord, G1
Hadfield, MG1
Milio, C1
Castañeda, E1
Whishaw, IQ1
Lermer, L1
Robinson, TE1
Taylor, MD1
de Ceballos, ML1
Chong, PN1
Tatton, WG1
Greenwood, CE1
Salo, PT1
Seniuk, NA1
Dluzen, D1
McDermott, J1
Sato, N1
Shimizu, H1
Shimomura, Y1
Uehara, Y1
Takahashi, M1
Negishi, M1
Yeung, JM1
Friedman, E1
Hetland, ML1
Bratholm, P1
Date, I1
Felten, DL1
Felten, SY1
Giorgi, O2
Porceddu, ML2
Pepitoni, S1
Serra, GP1
Biggio, G2
Walters, DE1
Chapman, CD1
Howard, SG1
Buu, NT1
Debinski, W1
Fornstedt, B1
Pileblad, E1
Carlsson, A1
Moretti, A2
Carfagna, N2
Trunzo, F2
Bruno, JP1
Jackson, D1
Stricker, EM1
Reinoso-Suárez, F1
McKeon, TW1
Hendley, ED1
Vaughn, DM1
Smyth, GB1
Whitmer, WL1
Satjawatcharaphong, C1
Ebert, MH1
Schmidt, DE1
McKinney, WT1
Tigges, M1
Fernandes, A1
Tigges, J1
Lun, A1
Szuecz, L1
Gross, J1
Horvath, G1
Nagy, I1
De Montis, G1
Mele, S1
MacRae, PG1
Spirduso, WW1
Walters, TJ1
Farrar, RP1
Wilcox, RE1
Roizen, MF1
Koblin, DD1
Johnson, BH1
Eger, EI1
Bainton, CR1
Lurz, FW1
Saitoh, T1
Niijima, K1
Mizuno, Y1
Cousin, KM1
Gerald, MC1
Uretsky, NJ1

Other Studies

164 other studies available for 3,4-dihydroxyphenylacetic acid and Aging

ArticleYear
Age-dependent dopaminergic dysfunction following fetal exposure to atrazine in SD rats.
    Environmental toxicology and pharmacology, 2014, Volume: 37, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Atrazine; Corpus Striatum; Dopamine; Dopamine Plasma

2014
Age-dependent effects of environmental enrichment on spatial memory and neurochemistry.
    Neurobiology of learning and memory, 2015, Volume: 118

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Environment; gamma-Aminobutyric Acid; Glut

2015
Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.
    Journal of psychiatry & neuroscience : JPN, 2017, Volume: 42, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Auditory Perception; Corpus Striatum; DiGeorge Syndr

2017
Altered Refractive Development in Mice With Reduced Levels of Retinal Dopamine.
    Investigative ophthalmology & visual science, 2016, Aug-01, Volume: 57, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biomarkers; Disease Models, Animal; Disease Progress

2016
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
    Journal of neurochemistry, 2017, Volume: 141, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aging; Antiparkinson Agents; Catecholamines; Dopamine;

2017
Significant effect of dimethylsulfoniopropionate on Parkinson's disease of senescence-accelerated mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Journal of nutritional science and vitaminology, 2008, Volume: 54, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Alzheimer Disea

2008
Differential susceptibility to extinction-induced despair and age-dependent alterations in the hypothalamic-pituitary-adrenal axis and neurochemical parameters.
    Neuropsychobiology, 2008, Volume: 58, Issue:3-4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Biomarkers; Depression; Dopamine;

2008
Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging.
    Experimental neurology, 2009, Volume: 216, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Analysis of Variance; Animals; Body Weight; Brai

2009
Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats.
    Synapse (New York, N.Y.), 2010, Volume: 64, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Bicuculline; Dopamine; Extracellular Space; GABA Ant

2010
Age-related changes in nigrostriatal dopaminergic function in heterozygous mutant dopamine transporter knock-out mice.
    Neuroscience letters, 2010, May-31, Volume: 476, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane

2010
Aged Tgfbeta2/Gdnf double-heterozygous mice show no morphological and functional alterations in the nigrostriatal system.
    Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Chromatography, High Pressure

2010
Effects of 6-hydroxydopamine lesioning of the medial prefrontal cortex on social interactions in adolescent and adult rats.
    Brain research, 2010, Jul-30, Volume: 1346

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Exploratory Behavior; Interpersonal Relati

2010
Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
    Neuroscience, 2010, Sep-01, Volume: 169, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Birth

2010
Impaired in vivo dopamine release in parkin knockout mice.
    Brain research, 2010, Sep-17, Volume: 1352

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Body Weight; Corpus Striatum; Dopamine; Homovanillic

2010
L-DOPA reverses motor deficits associated with normal aging in mice.
    Neuroscience letters, 2011, Feb-01, Volume: 489, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Dopamine; Dopamine Agents; H

2011
Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Journal of neurochemistry, 2012, Volume: 122, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; An

2012
Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans.
    Journal of neuroscience research, 2012, Volume: 90, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Aging; Animals; Antiparkinson Agents; Blott

2012
Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity.
    Molecular neurobiology, 2013, Volume: 47, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Glial Cell Line-Derived Neurotrophic Facto

2013
Influence of aging and social isolation on changes in brain monoamine turnover and biosynthesis of rats elicited by novelty stress.
    Synapse (New York, N.Y.), 2002, Volume: 46, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Brain; Chromatography, High Pre

2002
Aged Fischer 344 rats exhibit altered locomotion in the absence of decreased locomotor activity: exacerbation by nomifensine.
    Neuroscience letters, 2002, Nov-29, Volume: 333, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Analysis of Variance; Animals; Corpus Striatum;

2002
Microdialysis studies of D-amphetamine-evoked striatal dopamine overflow in young versus aged F344 rats: effects of concentration and order of administration.
    Brain research, 2003, Jul-25, Volume: 979, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Central Nervous System Stimulants; Chromatography, H

2003
Differential effects of post-implantation time on potassium- versus D-amphetamine-evoked dopamine overflow in the striatum of F344 rats.
    Neuroscience letters, 2003, Sep-11, Volume: 348, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dextroamphetamine; Dopamine; Extracellular Space; Mi

2003
Postnatal weight gain inhibition does not account for neurobehavioral consequences of neonatal Borna disease virus infection.
    Physiology & behavior, 2003, Volume: 80, Issue:2-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Animals, Newborn; Behavior, An

2003
Neonatal ventral hippocampus lesion alters the dopamine content in the limbic regions in postpubertal rats.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2004, Volume: 22, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Behavior, Animal; Denervation; Dis

2004
Long-term treatment with the antioxidant drug EGb 761 at senescence restored some neurobehavioral effects of chronic ultramild stress exposure seen in young mice.
    Neurobiology of aging, 2004, Volume: 25, Issue:8

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Behavior, Animal; Brain; Brain Chemist

2004
Differences in catecholamine metabolism and behaviour in neonatal broiler and layer chicks.
    British poultry science, 2004, Volume: 45, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Body Weight; Brain; Catecholamines; Chickens; Dopami

2004
Dopamine and GABA increases produced by activation of glutamate receptors in the nucleus accumbens are decreased during aging.
    Neurobiology of aging, 2005, Volume: 26, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Ana

2005
Brain aging phenomena in migrating sockeye salmon Oncorhynchus nerka nerka.
    Journal of neural transmission (Vienna, Austria : 1996), 2005, Volume: 112, Issue:9

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animal Migration; Animals; Antioxidants; Apoptosis; Brain; Ca

2005
Neonatal depletion of cortical dopamine: effects on dopamine turnover and motor behavior in juvenile and adult rats.
    Brain research. Developmental brain research, 2005, May-12, Volume: 156, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Aging; Analysis of Variance; Animals; Animals, Ne

2005
Variations of dopamine, serotonin, and amino acid concentrations in Noda epileptic rat (NER) retina.
    Brain research, 2006, Jan-27, Volume: 1070, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Animals, Newborn; Biogenic Monoamines;

2006
Brain catecholamine alterations and pathological features with aging in Parkinson disease model rat induced by Japanese encephalitis virus.
    Neurochemical research, 2006, Volume: 31, Issue:12

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Catecholamines; Dopamine; En

2006
Tranylcypromine enhancement of nicotine self-administration.
    Neuropharmacology, 2007, Volume: 52, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Benzazepines; Chromatography, High Pressure Liquid;

2007
Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Journal of neuroscience research, 2007, Volume: 85, Issue:8

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animal

2007
Aging and sex differences in striatal dopaminergic function.
    Neuroscience, 2007, Oct-26, Volume: 149, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amphetamine; Animals; Dopamine; Dopamine Uptake Inhibitors; F

2007
[Biochemical changes in 24-month-old Wistar rats].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1984, Volume: 178, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholinesterase; Aging; Animals; Choline; Choline O-Acetyltrans

1984
Regional changes in monoamine metabolism in the aging constant estrous rat.
    Neurobiology of aging, 1984,Winter, Volume: 5, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Corpus Striatum; Dopamine; Estrus; Female; Ho

1984
Influence of chronic inorganic lead exposure on regional dopamine and 5-hydroxytryptamine turnover in rat brain.
    Neurochemical research, 1984, Volume: 9, Issue:12

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Dopamine; Erythrocytes; Female; Homovanillic

1984
Changes in monoamines and their metabolite levels in some brain regions of aged rats.
    Neurobiology of aging, 1982,Spring, Volume: 3, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Dopamine; Homovanillic Acid; Hydroxyindoleace

1982
[Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    No to shinkei = Brain and nerve, 1982, Volume: 34, Issue:11

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Aged; Aging; Biogenic Amines; Chromatography, Hig

1982
Rat dopaminergic function in the retina during aging.
    Neurobiology of aging, 1981,Fall, Volume: 2, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Binding Sites; Corpus Striatum; Enkephalins; Male; P

1981
Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as drug for the elderly.
    Pharmacological research communications, 1983, Volume: 15, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Male; Propanolamines; Rats; Rats, Inbred Stra

1983
Catecholamine levels and turnover during aging in brain regions of male C57BL/6J mice.
    Brain research, 1981, Nov-16, Volume: 224, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Catecholamines; Dopamine; Epinephrine; Mice;

1981
Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice.
    Neurobiology of aging, 1981,Fall, Volume: 2, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Haloperidol; Male; Methyl

1981
The effects of morphine on catecholamine metabolism during postnatal development.
    Brain research, 1980, Sep-22, Volume: 197, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Medulla; Aging; Animals; Catecholamines; Corpus Striatum; Do

1980
Aging process affects a single class of dopamine receptors.
    Brain research, 1980, Dec-08, Volume: 202, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Aging; Animals; Corpus Striatum; Haloperidol; Hum

1980
Age-related changes on monoamine turnover in hippocampus of rats.
    Brain research, 1993, Dec-17, Volume: 631, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Hippocampus; Hydroxyindoleacetic Acid; Imm

1993
Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
    Teratology, 1993, Volume: 48, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amitriptyline; Amygdala; Analysis of Variance; Animals; Brain

1993
Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1994, Volume: 14, Issue:3 Pt 1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Caudate Nucleus; Disease Models, Animal; Dopa

1994
Effect of ageing on monoamine turnover in the prefrontal cortex of rats.
    Mechanisms of ageing and development, 1993, Dec-15, Volume: 72, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Dopamine; Homovanillic Acid; Hy

1993
Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
    Experimental neurology, 1994, Volume: 129, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Aging; Animals; Azides; Biogenic Amines; Cor

1994
Aging and the nigrostriatal dopamine system: a non-human primate study.
    Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration, 1994, Volume: 3, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analys

1994
Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.
    Neurochemical research, 1995, Volume: 20, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain;

1995
Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine.
    Mechanisms of ageing and development, 1995, Apr-21, Volume: 80, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Administration, Oral; Aging; Animals; Brain; Calcium

1995
A decreased tubular uptake of dopa results in defective renal dopamine production in aged rats.
    The American journal of physiology, 1995, Volume: 268, Issue:6 Pt 2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Aromatic-L-Amino-Acid Decarboxylases; Biological Tra

1995
Postnatal exposure to the beta-adrenoceptor agonist clenbuterol has regionally selective direct and long-term effects on rat brain beta-adrenoceptors and monoamine metabolism.
    Brain research. Developmental brain research, 1993, Jan-15, Volume: 71, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Brain; Cerebellum; Clenbuterol; Do

1993
Development of dopamine and N-methyl-D-aspartate systems in rat brain: the effect of prenatal phencyclidine exposure.
    Brain research. Developmental brain research, 1993, May-21, Volume: 73, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Female;

1993
Effects of genotype on age-related alterations in the concentrations of stress hormones in plasma and hypothalamic monoamines in rats.
    Journal of reproduction and fertility. Supplement, 1993, Volume: 46

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenocorticotropic Hormone; Aging; Animals; Biogenic Monoamines; Co

1993
Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study.
    Mechanisms of ageing and development, 1993, Volume: 67, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dialys

1993
Effects of EEDQ on the synthesis and metabolism of dopamine in preweanling and adult rats.
    Neuropharmacology, 1994, Volume: 33, Issue:12

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Suckling; Dihydroxyphenylalanine; Dopamine;

1994
MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels.
    Synapse (New York, N.Y.), 1994, Volume: 18, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbre

1994
Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 47, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Cannabinoids; Cannabis; Corpus Str

1994
Comparison of brain dopamine depletion induced by low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in young and aged rats.
    Neuroscience research, 1994, Volume: 20, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain;

1994
[Age-related changes in the dopaminergic system in rat striatum].
    Biulleten' eksperimental'noi biologii i meditsiny, 1993, Volume: 115, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Basal Metabolism; Corpus Striatum; Dopamine; Homovan

1993
Estradiol derived from testosterone in prenatal life affects the development of catecholamine systems in the frontal cortex in the male rat.
    Brain research, 1994, May-16, Volume: 646, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Aromatase Inhibitors; Catecholamin

1994
Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 44, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Caudate Nucleus; Chromatography

1993
Ontogeny of enhanced striatal dopamine release in rats with methamphetamine-induced behavioral sensitization.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 47, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Brain Chemistry; Chromatography, H

1994
Monoamine concentrations in cerebrospinal fluid of fetal and newborn sheep.
    The American journal of physiology, 1994, Volume: 266, Issue:2 Pt 2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Biogenic Monoamines; Dinoprostone;

1994
Calcium dependency and tetrodotoxin sensitivity of neostriatal dopamine release in 5-day-old and adult rats as measured by in vivo microdialysis.
    Journal of neurochemistry, 1994, Volume: 62, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Calcium; Dopamine; Kinetics; Micro

1994
Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1993, Volume: 9, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Dose-Response Relationshi

1993
The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on spontaneous release.
    Journal of neurochemistry, 1993, Volume: 61, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Apomorphine; Corpus Striatum; Dopamine; Dose-Respons

1993
Effects of ageing on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxic effects on striatum and brainstem in the rat.
    Neuroscience letters, 1993, Sep-03, Volume: 159, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Ascorbic Acid; Brain Stem; Corpus Stri

1993
Neonatal lateralization of behavior and brain dopaminergic asymmetry.
    Brain research bulletin, 1993, Volume: 32, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Dopamine; Female; Functional Later

1993
Ischemia-induced changes in brain monoamine metabolism in aged spontaneously hypertensive rats.
    Gerontology, 1993, Volume: 39, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Brain; Corpus Striatum; Dopamin

1993
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.
    European journal of pharmacology, 1993, Jan-12, Volume: 230, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Callithrix; Chromatography,

1993
Venous plasma noradrenaline increases with age: correlation to total blood volume and long-term smoking habits.
    Clinical physiology (Oxford, England), 1993, Volume: 13, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Aging; Benserazide; Blood Volume; Bo

1993
Effects of postnatal stress on dopamine mesolimbic system responses to aversive experiences in adult life.
    Brain research, 1993, Feb-26, Volume: 604, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Apomorphine; Dopamine; Female;

1993
Effects of estrogen upon dopamine release from the corpus striatum of young and aged female rats.
    Brain research, 1993, Mar-19, Volume: 606, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amphetamine; Animals; Corpus Striatum; Dopamine; Estrogens; F

1993
Altered in vivo catecholamine release in the hypothalamic paraventricular nucleus of the aged rat.
    Naunyn-Schmiedeberg's archives of pharmacology, 1996, Volume: 353, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Catecholamines; Homovanillic Acid; Male; Norepinephr

1996
Effects of chronic ethanol consumption and aging on dopamine, serotonin, and metabolites.
    Journal of neurochemistry, 1996, Volume: 66, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Alcohol Drinking; Animals; Brain; Dopamine; Hydroxyindoleacet

1996
Age-related changes in the metabolism of neurotransmitters in rat striatum: a microdialysis study.
    Mechanisms of ageing and development, 1996, Feb-24, Volume: 86, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Male; Microdialysis; Mono

1996
Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons.
    Journal of neurochemistry, 1996, Volume: 67, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Buthionine Sulfoximine; Corpus Striatu

1996
Free radical scavenging activity of the Japanese herbal medicine toki-shakuyaku-san (TJ-23) and its effect on superoxide dismutase activity, lipid peroxides, glutamate, and monoamine metabolites in aged rat brain.
    Neurochemical research, 1996, Volume: 21, Issue:8

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Bepridil; Biogenic Monoamines; Biphenyl

1996
Age-related changes in monoamines within the olfactory bulbs of the Fischer 344 male rat.
    Mechanisms of ageing and development, 1996, Oct-04, Volume: 91, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Dopamine; Male; Olfactory Bulb;

1996
Aging effects on monoamines in rat medial vestibular and cochlear nuclei.
    Hearing research, 1996, Volume: 100, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Anterior Hypothalamic Nucleus; Auditory Threshold; C

1996
Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.
    Journal of molecular neuroscience : MN, 1996,Winter, Volume: 7, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Brain; Dronabinol; Female; Gene Ex

1996
Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats.
    Neuroscience, 1997, Volume: 77, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Basal Ganglia; Denervation; Dopami

1997
Neuropeptide Y and [Leu31,Pro34]neuropeptide Y potentiate potassium-induced noradrenaline release in the paraventricular nucleus of the aged rat.
    Brain research, 1997, Mar-07, Volume: 750, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Cerebral Ventricles; Drug Synergism; Homovanillic Ac

1997
Preservation of autoreceptor-mediated increases in dopamine synthesis in aged mice with experimentally-induced parkinsonism.
    Neuroscience letters, 1997, Jan-31, Volume: 222, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Aromat

1997
Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra.
    Free radical biology & medicine, 1997, Volume: 23, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Blotting, Western; Dopamine; Dopamine Uptake Inhibit

1997
Pre/postnatal dopamine D1 receptor stimulation induces a differential reduction of serotonin levels in hippocampus and superior colliculus of puber rats.
    Neuroscience letters, 1997, Jul-18, Volume: 230, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Aging; A

1997
Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring.
    The American journal of physiology, 1997, Volume: 273, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Cortex; Aging; Analysis of Variance; Animals; Biogenic Monoa

1997
In vitro studies of endogenous noradrenaline and NPY overflow from the rat hypothalamus during maturation and ageing.
    Naunyn-Schmiedeberg's archives of pharmacology, 1998, Volume: 357, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Animals; Calcium; Chromatography, High Pressure

1998
Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats.
    Brain research, 1998, Jun-22, Volume: 797, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Aging; Animals; Brain Chemistry; Chrom

1998
The effects of repeated alcohol exposure on the neurochemistry of the periadolescent nucleus accumbens septi.
    Neuroreport, 1998, May-11, Volume: 9, Issue:7

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Alcoholism; Animals; Dopamine; Dose-Response Relationship, Dr

1998
Prenatal stress alters brain biogenic amine levels in primates.
    Development and psychopathology, 1998,Summer, Volume: 10, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Biogenic Amines; Brain; Female; Ho

1998
Changes with age in daytime and nighttime contents of melatonin, indoleamines, and catecholamines in the pineal gland: a comparative study in rat and Syrian hamster.
    Journal of pineal research, 1998, Volume: 25, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aging; Animals; Catecholamines; Circadian Rhyth

1998
Combined effect of obesity and aging on feeding-induced monoamine release in the rostromedial hypothalamus of the Zucker rat.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1998, Volume: 22, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Dopamine; Eating; Food; Hydroxy

1998
Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
    Brain research, 1999, Jan-16, Volume: 816, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Corpus Striatum; Dextroampheta

1999
Repeated cocaine exposure: effects on catecholamines in the nucleus accumbens septi of periadolescent animals.
    Pharmacology, biochemistry, and behavior, 1999, Volume: 62, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Catecholamines; Cocaine; Dopamine; Dopamine Uptake I

1999
An age-related decline in striatal taurine is correlated with a loss of dopaminergic markers.
    Brain research bulletin, 1999, Volume: 48, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biomarkers; Brain-Derived Neurotrophic Factor; Corpu

1999
[Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
    Biulleten' eksperimental'noi biologii i meditsiny, 1999, Volume: 127, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Administration, Intran

1999
GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
    Neuroscience, 1999, Volume: 92, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; G(M1) Ganglioside; Male;

1999
Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats.
    Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:4 Pt 1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Aromatic-L-Amino-Acid Decarbox

1999
Age-related dopamine deficiency in the mesostriatal dopamine system of zitter mutant rats: regional fiber vulnerability in the striatum and the olfactory tubercle.
    Neuroscience, 2000, Volume: 95, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antibodies; Disease Models, Animal; Dopamine; Free R

2000
Evaluation of L-DOPA biotransformation during repeated L-DOPA infusion into the striatum in freely-moving young and old rats.
    Brain research. Developmental brain research, 2000, May-11, Volume: 121, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antiparkinson Agents; Chromatography, High Pressure

2000
Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
    Annals of the New York Academy of Sciences, 2000, Volume: 914

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Area Under Curve; Body Temperature; Central Nervous

2000
DNA damage in brain mitochondria caused by aging and MPTP treatment.
    Brain research, 2000, Dec-01, Volume: 885, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Animals; Brain Chemistry; DNA Damage; DNA, Mitoc

2000
Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats.
    Journal of neuroendocrinology, 2001, Volume: 13, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Arcuate Nucleus of Hypothalamus; Bromocriptine; Dopa

2001
Changes in endogenous monoamines in aged rats.
    Clinical and experimental pharmacology & physiology, 2001, Volume: 28, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Catechol O-Methyltransferase; C

2001
Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats.
    Pharmacology, biochemistry, and behavior, 2001, Volume: 68, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Caud

2001
Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.
    Brain research, 2001, Mar-30, Volume: 896, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Cell Survival; Dopamine; Glial Cell Line-Derived Neu

2001
Carbachol effect on carotid body dopamine in vitro release in response to hypoxia in adult and pup rabbit.
    Neuroscience research, 2001, Volume: 40, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Carbachol; Carotid Body; Cholinergic Agonists; Dopam

2001
Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
    Neuroscience, 2001, Volume: 105, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Dopamine; Dopamine Agonists; Dopam

2001
Heart failure, aging, and renal synthesis of dopamine.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Age Factors; Aged; Aging; Aldosterone; Cardiac Output, Low; C

2001
Aging increases the susceptiblity to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia.
    Journal of neurochemistry, 2001, Volume: 78, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain Chemistry; Central Nervous System Stimulants;

2001
Prenatal cocaine exposure increases mesoprefrontal dopamine neuron responsivity to mild stress.
    Synapse (New York, N.Y.), 2001, Volume: 42, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Cocaine; Cocaine-Related Disorders; Dopamine; Electr

2001
Changes in the cochlear dopaminergic system of the aged rat.
    Brain research, 2001, Oct-26, Volume: 917, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Chromatography, High Pressure Liquid; Cochlea; Dopam

2001
Effects of aging on cochlear monoamine turnover.
    Advances in oto-rhino-laryngology, 2002, Volume: 59

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Chromatography, High Pressure L

2002
Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome.
    Neural plasticity, 2001, Volume: 8, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Alanine; Amino Acids; Animals; Aspartic Acid; Brain; Brain St

2001
Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain.
    Annals of the New York Academy of Sciences, 2002, Volume: 965

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Apoptosis; Brain; Dopamine; Female; Homovanillic Aci

2002
Neonatal exposure to cocaine: altered dopamine levels in the amygdala and behavioral outcomes in the developing rat.
    Annals of the New York Academy of Sciences, 2002, Volume: 965

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amygdala; Animals; Animals, Newborn; Cocaine; Dopamine; Femal

2002
Determination of some L-3,4-dihydroxyphenylalanine and dopamine metabolites in urine by means of mass fragmentography.
    Clinical chemistry, 1978, Volume: 24, Issue:1

    Topics: 3-Methoxy-4-hydroxyphenylethanol; 3,4-Dihydroxyphenylacetic Acid; Adult; Aging; Child; Child, Presch

1978
Age-related changes in catecholamine metabolites of human urine from birth to adulthood.
    Journal of neural transmission, 1979, Volume: 46, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Aging; Catecholamines; Child; Child, Preschool; D

1979
Postnatal development of dopamine deamination in the striatum of the rat.
    British journal of pharmacology, 1975, Volume: 55, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Deamination; Dopamine; Female; Homo

1975
Effect of alpha-human atrial natriuretic peptide on the synthesis of dopamine in the rat kidney.
    British journal of pharmacology, 1992, Volume: 105, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; 3',5'-Cyclic-GMP Phosphodiesterases; Aging; Animals; Atrial Natriure

1992
Comparisons between brain dopaminergic neurons of juvenile and aged rats: sex-related differences.
    Mechanisms of ageing and development, 1992, Mar-15, Volume: 63, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Dopamine; Female; Male; Neurons; Rats; Rats,

1992
Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging.
    Brain research. Molecular brain research, 1992, Volume: 13, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acid Sequence; Animals; Biogenic Monoamines; Corpus Str

1992
Dopaminergic neuron development in rats: biochemical study from prenatal life to adulthood.
    Brain research bulletin, 1992, Volume: 29, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Female; Hydroxyindoleacetic Acid; Mesencep

1992
Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Neuropharmacology, 1992, Volume: 31, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus

1992
Neuroendocrine responses to social regulation of puberty in the female house mouse.
    Neuroendocrinology, 1992, Volume: 55, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Estradiol; Female; Hypothalamus; Hypothala

1992
[Development in the metabolism of dopamine and its derivatives. Application to gross development disorders].
    Neurophysiologie clinique = Clinical neurophysiology, 1992, Volume: 22, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Autistic Disorder; Child; Child, Presch

1992
Regional brain monoamine levels and utilization in middle-aged rats.
    Life sciences, 1990, Volume: 46, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Brain; Dopamine; Hydroxyindolea

1990
Dopamine depletion in neonatal rats: effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood.
    Brain research, 1990, Jan-29, Volume: 508, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Behavior, Animal; Corpus Striatum;

1990
Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats.
    Journal of neurochemistry, 1991, Volume: 56, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Hydraz

1991
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTP.
    Journal of neural transmission. Parkinson's disease and dementia section, 1991, Volume: 3, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Basal

1991
Transmitter synthesis increases in substantia nigra neurons of the aged mouse.
    Neuroscience letters, 1991, Oct-14, Volume: 131, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Axonal Transport; Corpus Striatum; Dihydroxyphenylal

1991
Age effects on monoamine turnover of the rat substantia nigra.
    Brain research, 1991, Aug-23, Volume: 557, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aging; Animals; Aromatic Amino Acid Decarboxyla

1991
Striatal dopamine release in vitro from immature male rats shows enhanced responsiveness to pulsatile, but not continuous, infusions of L-dopa.
    Brain research. Developmental brain research, 1991, Oct-21, Volume: 62, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Levodopa; Male; Pulsatile

1991
A study on the renal synthesis of dopamine in aged rats.
    Acta physiologica Scandinavica, 1991, Volume: 143, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Chromatography, High Pressure Liquid; Dopamine; Kidn

1991
Sucrose feeding at weaning alters the preference for sucrose in adolescence.
    Experimental and clinical endocrinology, 1991, Volume: 98, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Chromatography, High Pressure Liquid; Dopamine; Drin

1991
Effect of aging and diet restriction on monoamines and amino acids in cerebral cortex of Fischer-344 rats.
    Growth, development, and aging : GDA, 1991,Winter, Volume: 55, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Biogenic Monoamines; Cerebral Cortex; C

1991
The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
    Scandinavian journal of clinical and laboratory investigation, 1991, Volume: 51, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Catecholamine

1991
The effect of long-term treatment with deprenyl on basal and L-dopa evoked dopamine release in vitro from the corpus striatum of aged rats.
    Journal of neural transmission. General section, 1991, Volume: 85, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amphetamine; Animals; Corpus Striatum; Dopamine; In Vitro Tec

1991
Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.
    Brain research, 1990, Jun-11, Volume: 519, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain;

1990
Differential effect of aging on 3H-SCH 23390 binding sites in the retina and in distinct areas of the rat brain.
    Journal of neural transmission. General section, 1990, Volume: 82, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Benzazepines; Brain Chemistry; Cerebral Cortex; Corp

1990
Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
    Journal of neurochemistry, 1990, Volume: 54, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dialysis; Dopamine; Female; Haloper

1990
Vesicular and ganglionic norepinephrine in the rat: progressive increase with age.
    Journal of neurochemistry, 1990, Volume: 54, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Catecholamines; Chromatography, High Pressure

1990
In vivo autoxidation of dopamine in guinea pig striatum increases with age.
    Journal of neurochemistry, 1990, Volume: 55, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Cerebral Cortex; Corpus Striatum; Cysteinyldo

1990
Effect of aging on monoamines and their metabolites in the rat brain.
    Neurochemical research, 1987, Volume: 12, Issue:11

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Dopamine; Homovanillic Acid;

1987
Effect of dopamine-depleting brain lesions in rat pups: role of striatal serotonergic neurons in behavior.
    Behavioral neuroscience, 1987, Volume: 101, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Behavior, Animal; Brain; Corpus St

1987
Changes in biogenic amines in rat hippocampus during development and aging.
    Life sciences, 1988, Volume: 42, Issue:24

    Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aging; Animals; Dopamine; Hippocampus; Homovani

1988
Brain monoamines and metabolites in hypertensive and hyperactive rat strains.
    Clinical and experimental hypertension. Part A, Theory and practice, 1988, Volume: 10, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Brain Chemistry; Dopamine; Fema

1988
Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
    Veterinary research communications, 1989, Volume: 13, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Cisterna Magna; Female; Homovan

1989
A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1989, Volume: 2, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Amines; Female; Homovanillic Acid; Hydroxyi

1989
Dopamine synthesis and metabolism in rhesus monkey retina: development, aging, and the effects of monocular visual deprivation.
    Visual neuroscience, 1989, Volume: 2, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Dopamine; Macaca mulatta; Osmolar

1989
Age-related changes of catecholamines and their metabolites content in the visual system of the rat.
    Mechanisms of ageing and development, 1989, Volume: 47, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Catecholamines; Dopamine; Geniculate Bodies; Homovan

1989
Effect of mild postnatal hypoxia and L-dopa administration on dopamine concentration in striata of the newborn rat and long term sequelae on dopamine turnover.
    Biomedica biochimica acta, 1989, Volume: 48, Issue:2-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Hypoxia

1989
Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Brain research, 1987, Volume: 432, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Aging; Animals; Benzazepines; Binding Sites; Corp

1987
Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolites in presenescent older rats.
    Psychopharmacology, 1987, Volume: 92, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Kineti

1987
Mechanism of age-related and nitrous oxide-associated anesthetic sensitivity: the role of brain catecholamines.
    Anesthesiology, 1988, Volume: 69, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain Chemistry; Dopamine; Drug Resistance; Male; Mi

1988
Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice.
    Journal of the neurological sciences, 1987, Volume: 77, Issue:2-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus

1987
The change with age in biogenic amines and their metabolites in the striatum of the rat.
    Archives of gerontology and geriatrics, 1986, Volume: 5, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Animals; Biogenic Amines; Corpus Striatum; Dopam

1986
Effect of nialamide on the metabolism of dopamine injected into the nucleus accumbens of old rats.
    The Journal of pharmacology and experimental therapeutics, 1986, Volume: 237, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Homovanillic Acid; Limbic System; Male; Mo

1986
Brain catecholamine content and turnover in aging rats.
    Experimental gerontology, 1985, Volume: 20, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; alpha-Methyltyrosine; Animals; Brain; Catecholamines; Corpus

1985